{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:03:22Z","timestamp":1792627402749,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014816","name":"GWIS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01 AI097092-07"],"award-info":[{"award-number":["P01 AI097092-07"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["\/NIAID 1R21AI146529"],"award-info":[{"award-number":["\/NIAID 1R21AI146529"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI145870-03"],"award-info":[{"award-number":["R01 AI145870-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002581","name":"School of Medicine, CHA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000374","name":"British Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002077","name":"Epidermolysis Bullosa Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ymthe.2022.01.011","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T21:16:03Z","timestamp":1641503763000},"page":"2024-2047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice"],"prefix":"10.1016","volume":"30","author":[{"given":"Carly M.","family":"Bliss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec W.","family":"Freyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Caniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.","family":"Leyva-Grado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Nachbagauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia L.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.01.011_bib1","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","article-title":"Influenza: old and new threats","volume":"10","author":"Palese","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib2","doi-asserted-by":"crossref","first-page":"607333","DOI":"10.3389\/fimmu.2020.607333","article-title":"Adenoviral vectors as vaccines for emerging avian influenza viruses","volume":"11","author":"Kerstetter","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming barriers in the path to a universal influenza virus vaccine","volume":"24","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2022.01.011_bib4","doi-asserted-by":"crossref","first-page":"2100439","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100439","article-title":"Isolation of clade 2.3.4.4b A(H5N8), a highly pathogenic avian influenza virus, from a worker during an outbreak on a poultry farm, Russia, December 2020","volume":"26","author":"Pyankova","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ymthe.2022.01.011_bib5","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1073\/pnas.1816300116","article-title":"Outflanking immunodominance to target subdominant broadly neutralizing epitopes","volume":"116","author":"Angeletti","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.01.011_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI123366","article-title":"Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem","volume":"129","author":"Tan","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.01.011_bib7","doi-asserted-by":"crossref","first-page":"20248","DOI":"10.1073\/pnas.1320524110","article-title":"Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins","volume":"110","author":"Heaton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.01.011_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/v8060155","article-title":"Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin","volume":"8","author":"Doud","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2022.01.011_bib9","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-018-03665-3","article-title":"How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin","volume":"9","author":"Doud","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.01.011_bib10","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.01.011_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.15585\/mmwr.mm6706a2","article-title":"Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018","volume":"67","author":"Flannery","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.ymthe.2022.01.011_bib12","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.5.18-00035","article-title":"Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017\/18 vaccine effectiveness, Canada, January 2018","volume":"23","author":"Skowronski","year":"2018","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ymthe.2022.01.011_bib13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.43.17-00707","article-title":"Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017","volume":"22","author":"Sullivan","year":"2017","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ymthe.2022.01.011_bib14","doi-asserted-by":"crossref","first-page":"1900121","DOI":"10.2807\/1560-7917.ES.2019.24.1900121","article-title":"Interim 2018\/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019","volume":"24","author":"Kissling","year":"2019","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ymthe.2022.01.011_bib15","doi-asserted-by":"crossref","first-page":"2000153","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000153","article-title":"Interim 2019\/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020","volume":"25","author":"Rose","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ymthe.2022.01.011_bib16","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ni.2761","article-title":"Universal influenza virus vaccines: need for clinical trials","volume":"15","author":"Krammer","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib18","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.01.011_bib19","doi-asserted-by":"crossref","first-page":"e1006682","DOI":"10.1371\/journal.ppat.1006682","article-title":"A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine","volume":"13","author":"Wu","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2022.01.011_bib20","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1016\/j.vaccine.2018.05.086","article-title":"Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain","volume":"36","author":"Garretson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2022.01.011_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.01.011_bib24","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.01.011_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ymthe.2022.01.011_bib26","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ymthe.2022.01.011_bib27","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.011_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","article-title":"Novel correlates of protection against pandemic H1N1 influenza A virus infection","volume":"25","author":"Ng","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib31","doi-asserted-by":"crossref","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0969-2126(97)00233-5","article-title":"Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain","volume":"5","author":"Tao","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.ymthe.2022.01.011_bib33","doi-asserted-by":"crossref","first-page":"e43603","DOI":"10.1371\/journal.pone.0043603","article-title":"A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates","volume":"7","author":"Krammer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.011_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.01.011_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.01.011_bib36","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1128\/JVI.00969-13","article-title":"In\u00a0vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies","volume":"87","author":"Heaton","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib37","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.ymthe.2022.01.011_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination","volume":"103","author":"Hannoun","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.ymthe.2022.01.011_bib39","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J.\u00a0Hyg. (Lond)"},{"key":"10.1016\/j.ymthe.2022.01.011_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/vaccines3020373","article-title":"Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2022.01.011_bib41","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/infdis\/jiz583","article-title":"Early induction of cross-reactive CD8+ T-cell responses in tonsils after live-attenuated influenza vaccination in children","volume":"221","author":"Mohn","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.011_bib42","doi-asserted-by":"crossref","first-page":"e85832","DOI":"10.1172\/jci.insight.85832","article-title":"Vaccine-generated lung tissue-resident memory T\u00a0cells provide heterosubtypic protection to influenza infection","volume":"1","author":"Zens","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2022.01.011_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/vaccines6020018","article-title":"Harnessing the power of T\u00a0cells: the promising hope for a universal influenza vaccine","volume":"6","author":"Clemens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2022.01.011_bib44","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nm.3958","article-title":"Endogenous antigen processing drives the primary CD4+ T\u00a0cell response to influenza","volume":"21","author":"Miller","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib45","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2007-02-062117","article-title":"Adenoviral vectors persist in\u00a0vivo and maintain activated CD8+ T\u00a0cells: implications for their use as vaccines","volume":"110","author":"Tatsis","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.01.011_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.omtm.2019.12.003","article-title":"Targeting antigen to the surface of EVs improves the in\u00a0vivo immunogenicity of human and non-human adenoviral vaccines in mice","volume":"16","author":"Bliss","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.01.011_bib47","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag","volume":"170","author":"Fitzgerald","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib48","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/JVI.02058-12","article-title":"Alternative serotype adenovirus vaccine vectors elicit memory T\u00a0cells with enhanced anamnestic capacity compared to Ad5 vectors","volume":"87","author":"Penaloza-MacMaster","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JVI.02055-12","article-title":"Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T\u00a0cells induced by different adenovirus vectors","volume":"87","author":"Tan","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib50","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.4049\/jimmunol.1202861","article-title":"Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T\u00a0cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization","volume":"190","author":"Quinn","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"A brief history of T\u00a0cell help to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib52","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.00450-10","article-title":"Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae","volume":"84","author":"Chen","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib53","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ymthe.2022.01.011_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in\u00a0vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.01.011_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.01.011_bib57","first-page":"1","article-title":"Broadly neutralizing antibodies target a hemagglutinin anchor epitope","author":"Guthmiller","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.011_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1900022","article-title":"Chimeric hemagglutinin-based influenza virus vaccines induce protective stalk-specific humoral immunity and cellular responses in mice","volume":"3","author":"Choi","year":"2019","journal-title":"Immunohorizons"},{"key":"10.1016\/j.ymthe.2022.01.011_bib59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/infdis\/jix292","article-title":"The hemagglutinin A stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses","volume":"216","author":"Paules","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.011_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01603-17","article-title":"In\u00a0vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice","volume":"91","author":"Sutton","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model","volume":"91","author":"Ermler","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib62","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1016\/j.vaccine.2020.07.008","article-title":"Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection","volume":"38","author":"Kavian","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib63","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.vaccine.2020.01.008","article-title":"Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay","volume":"38","author":"Chromikova","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib64","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2022.01.011_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2022.01.011_bib66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/371080a0","article-title":"Crystal structure of an isoleucine-zipper trimer","volume":"371","author":"Harbury","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.011_bib67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.011_bib68","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1164\/rccm.200511-1751OC","article-title":"Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice","volume":"174","author":"Xu","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The pathway to a universal influenza vaccine","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2022.01.011_bib70","doi-asserted-by":"crossref","first-page":"115ra112","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib71","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.vaccine.2015.01.042","article-title":"The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species","volume":"33","author":"Dicks","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.011_bib73","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2022.01.011_bib74","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib75","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ymthe.2016.11.003","article-title":"Viral vector malaria vaccines induce high-level T\u00a0cell and antibody responses in west African children and infants","volume":"25","author":"Bliss","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.011_bib76","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib77","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1-2a trial of Ad26.COV2.S Covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2022.01.011_bib79","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2022.01.011_bib80","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.vaccine.2017.04.026","article-title":"Spray dried human and chimpanzee adenoviral-vectored vaccines are thermally stable and immunogenic in\u00a0vivo","volume":"35","author":"Afkhami","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib81","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib82","doi-asserted-by":"crossref","first-page":"e0006870","DOI":"10.1371\/journal.pntd.0006870","article-title":"A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis","volume":"12","author":"Wang","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2022.01.011_bib83","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3301527","article-title":"Development of formulations that enhance physical stability of viral vectors for gene therapy","volume":"8","author":"Croyle","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2022.01.011_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2018.06.001","article-title":"Stability and suitability for storage and distribution of Ad26.ZEBOV\/MVA-BN(R)-Filo heterologous prime-boost Ebola vaccine","volume":"129","author":"Capelle","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ymthe.2022.01.011_bib85","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1016\/j.vaccine.2019.07.095","article-title":"Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice","volume":"37","author":"Asthagiri Arunkumar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib86","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3389\/fimmu.2019.02005","article-title":"Vaccination with viral vectors expressing chimeric hemagglutinin, NP and M1 antigens protects ferrets against influenza virus challenge","volume":"10","author":"McMahon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib87","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3389\/fmicb.2019.02031","article-title":"Soluble recombinant hemagglutinin protein of H1N1pdm09 influenza virus elicits cross-protection against a lethal H5N1 challenge in mice","volume":"10","author":"Yamada","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib88","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.011_bib90","doi-asserted-by":"crossref","first-page":"e115161","DOI":"10.1371\/journal.pone.0115161","article-title":"A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates Chad63 CS administered alone and with MVA CS","volume":"9","author":"de Barra","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.011_bib91","doi-asserted-by":"crossref","first-page":"e1005578","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2022.01.011_bib92","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2022.01.011_bib93","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib94","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/cmi.2016.20","article-title":"Identification of a CD4 T-cell epitope in the hemagglutinin stalk domain of pandemic H1N1 influenza virus and its antigen-driven TCR usage signature in BALB\/c mice","volume":"14","author":"Lu","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/pathogens8040220","article-title":"Peptide epitope hot spots of CD4 T\u00a0cell recognition within influenza hemagglutinin during the primary response to infection","volume":"8","author":"Knowlden","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.ymthe.2022.01.011_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00947-19","article-title":"Protein vaccination directs the CD4(+) T\u00a0cell response toward shared protective epitopes that can be recalled after influenza virus infection","volume":"93","author":"Rattan","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib97","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T\u00a0cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib98","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1128\/JVI.07172-11","article-title":"Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection","volume":"86","author":"Brown","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib99","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jiu616","article-title":"Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses","volume":"211","author":"Nayak","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2022.01.011_bib100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","article-title":"Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine","volume":"32","author":"Atsmon","year":"2012","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib101","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T\u00a0cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.01.011_bib102","doi-asserted-by":"crossref","first-page":"e1003207","DOI":"10.1371\/journal.ppat.1003207","article-title":"Cooperativity between CD8+ T\u00a0cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity","volume":"9","author":"Laidlaw","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2022.01.011_bib103","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T\u00a0cell-mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2022.01.011_bib104","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib105","first-page":"417","article-title":"Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in\u00a0vivo","volume":"58","author":"Taylor","year":"1986","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2022.01.011_bib106","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2020.00909","article-title":"Factors which contribute to the immunogenicity of non-replicating adenoviral vectored vaccines","volume":"11","author":"Coughlan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib107","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature06664","article-title":"The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response","volume":"452","author":"Muruve","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.011_bib108","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/JVI.01597-10","article-title":"Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors","volume":"85","author":"Rhee","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib109","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.vaccine.2016.08.051","article-title":"An inflammatory response is essential for the development of adaptive immunity-immunogenicity and immunotoxicity","volume":"34","author":"Nakayama","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2022.01.011_bib110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.01.011_bib111","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.01.011_bib112","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1074\/jbc.M114.620534","article-title":"Immunosilencing a highly immunogenic protein trimerization domain","volume":"290","author":"Sliepen","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.01.011_bib113","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.01.011_bib114","doi-asserted-by":"crossref","first-page":"e0128779","DOI":"10.1371\/journal.pone.0128779","article-title":"A cysteine zipper stabilizes a pre-fusion F glycoprotein vaccine for respiratory syncytial virus","volume":"10","author":"Stewart-Jones","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.011_bib115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"Smith","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2022.01.011_bib116","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1128\/JVI.01065-06","article-title":"Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines","volume":"80","author":"Wang","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2022.01.011_bib117","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.011_bib118","doi-asserted-by":"crossref","first-page":"e112302","DOI":"10.1371\/journal.pone.0112302","article-title":"A recommended numbering scheme for influenza A HA subtypes","volume":"9","author":"Burke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2022.01.011_bib119","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:05:54Z","timestamp":1778616354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1525001622000119"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}